Ph1 FIH JZP898 +/- PD-1/PD-L1 with met Solid Tumors

Phase I Clinical Trial

JZP898-101: A Phase 1 first-in-human open-label multicenter study of JZP898 as monotherapy and in combination with pembrolizumab in participants with advanced or metastatic solid tumors

Indication: Colon Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Melanoma, Rectal Cancer, Renal Cancer, Urothelial Cancer

Trial Number: 06108050

Trial Status: Call Proj Mgr

Learn more about this clinical trial.

Ph1 FIH JZP898 +/- PD-1/PD-L1 with met Solid Tumors

Phase I Clinical Trial

Participating Locations